Abstract Inflammatory reactions are the most critical pathological processes occurring after spinal cord injury (SCI). Activated microglia/macrophages have either detrimental or beneficial effects on neural regeneration based on their functional polarized M1/M2 subsets. However, the mechanism of microglia/macrophage polarization to M1/M2 at the injured spinal cord environment remains unknown. In this study, wild-type (WT) or aldose reductase (AR)-knockout (KO) mice were subjected to SCI by a spinal crush injury model. The expression pattern of AR, behavior tests for locomotor activity, and lesion size were assessed at between 4 h and 28 days after SCI. We found that the expression of AR is upregulated in microglia/macrophages after SCI in WT mice. In AR KO mice, SCI led to smaller injury lesion areas compared to WT. AR deficiency-induced microglia/macrophages induce the M2 rather than the M1 response and promote locomotion recovery after SCI in mice. In the in vitro experiments, microglia cell lines (N9 or BV 2 ) were treated with the AR inhibitor (ARI) fidarestat. AR inhibition caused 4-hydroxynonenal (HNE) accumulation, which induced the phosphorylation of the cAMP response element-binding protein (CREB) to promote Arg1 expression. KG501, the specific inhibitor of phosphorylated CREB, could cancel the upregulation of Arg1 by ARI or HNE stimulation. Our results suggest that AR works as a switch which can regulate microglia by polarizing cells to either the M1 or the M2 phenotype under M1 stimulation based on its states of activity. We suggest that inhibiting AR may be a promising therapeutic method for SCI in the future.
Introduction
Spinal cord injury (SCI) is one of the most debilitating diseases with poor prognosis worldwide. Traumatic damage triggers a complex local inflammatory response, a critical pathophysiological process following a secondary injury after SCI. At the spinal cord lesion site, microglia/macrophages derived from both residential microglia and hematogenous macrophages or from activated microglia and infiltrated macrophages, respectively, cannot be distinguished based on their morphology or specific molecular markers [1] . Microglia/ macrophages have either detrimental or beneficial effects on neural regeneration based on their two extreme functional polarized subsets, "classically activated" pro-inflammatory (M1) or "alternatively activated" anti-inflammatory (M2) cells [2] [3] [4] [5] [6] . In response to lipopolysaccharide (LPS) and the proinflammatory cytokine interferon-γ (IFN-γ), macrophages undergo M1 polarization characterized by the expression of pro-inflammatory cytokines and cytotoxic mediators (reactive oxygen and nitrogen species), as well as increase their phagocytic and antigen-presenting capacity. In contrast, activated macrophages in the presence of IL-4 or IL-13 undergo M2 polarization characterized by the expression of antiinflammatory cytokines, which contribute to the termination of inflammation [1, 7, 8] . Kigerl et al. reported that most microglia/macrophages are polarized to M1 cells, with only a transient and small number in M2 polarization [6] . In vitro, they showed that M1 macrophages are neurotoxic and possess only moderate axon growth-promoting effects. In contrast, M2 macrophages can promote long-distance axon growth, even in the presence of potent growth-inhibitory substrates [6] .
One of the well-characterized pathological processes occurring early after SCI is the formation of reactive nitrogen species (RNS) and reactive oxygen species (ROS) [9, 10] . RNS and ROS cause lipid oxidation as well as nitrative and oxidative damage to proteins and nucleic acids, leading to neuronal loss by necrosis or apoptosis [10, 11] . Microglia/ macrophages are the major cells that produce neurotoxic RNS and ROS after SCI [12] . ROS-mediated activation of redoxsensitive transcription factors, such as nuclear factor-kappa B (NF-κB) and activator protein (AP)-1, as well as subsequent expression of pro-inflammatory cytokines, chemokines, and growth factors are characteristics of inflammatory diseases [13, 14] . Cytokines and LPS cause oxidative stress to form toxic lipid aldehydes such as 4-hydroxynonenal (HNE), which triggers multiple signaling cascades that variably affect cell growth, differentiation, and apoptosis through lipid peroxidation [15] .
Aldose reductase (AKR1B1, AR) belongs to the aldoketo reductase (AKR) superfamily, which includes several enzymes that catalyze oxidation and reduction reactions involved in various cellular processes [14] . AR is the only enzyme responsible for reducing glucose to sorbitol in the polyol pathway of glucose metabolism [16] . Recent studies have suggested that glucose may be an incidental substrate of AR, which appears to be good at catalyzing the reduction of a wide range of aldehydes generated from lipid peroxidation. Several reports showed that AR, in addition to reducing glucose, efficiently reduces the lipid peroxidation-derived aldehydes such as HNE and is thought to be the preferred physiological substrate with higher affinity than glucose [14] . Pharmacological inhibition or small interfering RNA (siRNA) ablation of AR prevented the biosynthesis of TNF-α, IL-1β, IL-6, macrophage-chemoattractant protein (MCP)-1, cyclooxygenase-2 (Cox-2), and prostaglandin E2 (PGE2) in LPS-activated RAW264.7 murine macrophages. AR inhibition or ablation significantly attenuated LPS-induced activation of protein kinase C (PKC) and phospholipase C (PLC), nuclear translocation and phosphorylation of NF-κB, and proteolytic degeneration of IκBα in macrophages [17] . These results i n d i c a t e t h a t A R c a n p r o m o t e L P S -i n d u c e d inflammatory signals in macrophages by promoting NF-κB-dependent expression of inflammatory cytokines and chemokines. Whether AR plays a role in M1 or M2 polarization of microglia/macrophages and in neuroinflammation after SCI remains unclear. In this study, we found that messenger RNA (mRNA) and protein levels of AR increased in a time-dependent manner after SCI. In AR −/− mice, activated microglia/macrophages at the injured site were prone to M2 rather than M1 polarization during early stages of SCI. HNE, the substrate of AR, accumulated in microglia treated with an AR inhibitor inducing transcript factor cAMP response element-binding protein (CREB) upregulation and phosphorylation, which promoted microglia polarization to M2.
Materials and Methods
Animals and SCI Model AR −/− mice generated previously and backcrossed to C57BL/ 6 mice for more than ten generations, which are considered to be congenic with C57BL/6 mice, were used (n=53) [18] . Age-matched normal C57BL/6 (n=55) (SLAC, Shanghai, China) were used as control wild-type mice (AR +/+ ). Mice were housed in a specific pathogen-free (SPF) environment at the animal facility of the Department of Neurobiology, the Fourth Military Medical University. All procedures were conducted under guidelines approved by the Fourth Military Medical University Animal Care and Use Committee. Anesthetized mice with 1 % sodium pentobarbital (Sigma-Aldrich, 40 mg/kg) received a severe spinal crush injury as described previously with certain modifications [19] . Briefly, a laminectomy was performed at vertebral midthoracic level T8-T10 leaving the dura intact. SCI was made at the level of T8 by compressing the cord laterally from both sides for 20 s with number 5 Dumont forceps (Fine Science Tools) modified with a spacer of 0.25 mm to produce severe injury. A sham group was generated by only performing laminectomy but no compression of the cord. Postoperatively, mice received manual bladder evacuation twice a day to prevent urinary tract infections until normal voiding reflexes returned.
Behavioral Assessment
Gross locomotor recovery after SCI was assessed using the Basso Mouse Scale (BMS) hind limb locomotor test for mice [20] . For 1 week before surgery, mice were acclimated to the testing field. At 0, 3, 5, 7, 14, and 28 days postinjury (dpi), mice were placed in this field and observed with video record for 4 min. Each hind limb was scored by two investigators blinded to the treatment protocol.
Estimation of Lesion Area
Spaced serial 10-μm-thick sections 100 μm apart were stained with Luxol Fast Blue (LFB, Sigma-Aldrich) [21] . Briefly, the sections were dehydrated and incubated in 0.1 % LFB dissolved in 95 % ethanol at 60°C overnight. Stained sections were cooled at RT and differentiated in 0.05 % lithium carbonate and 70 % ethanol. Sections were then counterstained with 0.1 % Cresyl Violet (Sigma-Aldrich) at 60°C for 10 min and mounted in neural resin. Digital images were acquired using a DP70 digital camera (Olympus) mounted on a BX51 Olympus microscope equipped with a ×10 objective. Five random sections were quantified per mouse and three mice of each kind were measured per group. Quantification of LFBstained areas was performed using Photoshop CS3 software.
Cell Cultures

Microglial Cell Line Culture
The murine microglial cell line N9 (kept in our lab) or BV2 was cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco) supplemented with 5% fetal bovine serum (FBS; Gibco), 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. A volume of 5×10 5 cells were seeded onto 12-well plates. To detect the polarization of N9 microglia, cells were treated with LPS (100 ng/ml; SigmaAldrich) or IL-4 (20 ng/ml; R&D Systems), respectively, combined with fidarestat 20 μM (Lot. 308002, Sanwa Kagaku Kenkyusho, Nagoya, Japan) following two strategies. One was first to stimulate N9 cells with the above cytokines for 24 h, respectively, and then add an AR inhibitor (ARI) for another 24 h. The other was first to treat N9 cells with ARI for 24 h and then add the cited cytokines, respectively, for another 24 h. After those treatments, N9 cells were washed with DHank's solution for three times and harvested for further analysis with quantitative PCR (qPCR) or Western blot.
Primary Cortical Neuron Cultures
Primary cortical neurons were prepared from wild-type (C57BL/6) and AR-deficient mouse at E15 [22] . Using aseptic technique, the fetal brains were removed and transferred into ice-cold D-Hank's medium without Ca 2+ and Mg 2+ . After, bilateral cortices were mechanically separated and the meninges were carefully removed using fine forceps (SigmaAldrich, style #7). Then, the cerebral cortex was minced using sterile iridectomy scissors. These pieces were incubated in Ca 2+ -and Mg
2+
-free D-Hank's balanced salt solution with 0.125 % trypsin and 0.1 % DNase at 37°C for 15 min. The enzymatic digestion was followed by a brief mechanical trituration using polished Pasteur pipettes and centrifuged at 800 rpm for 5 min. Cells were suspended in Neurobasal A (Gibco) supplemented with B27 (Gibco) and 2 mM L-glutamine. Cell suspensions were seeded in poly-L-lysine (25 μg/ml, Sigma)-coated 6-well culture plates at a density of 4×10 4 cells/cm 2 at 37°C/5 % CO 2 for 7-14 days of culture. The cell populations consisted of >95 % neurons before used, which was determined by immunocytochemical stain with anti-neuron-specific β-tubulin III (data not shown) [23] .
Primary Astrocyte Cultures
Primary astrocytes were cultured from the cerebral cortex of 1-2-day postnatal mouse pups [24] . The cerebral cortices were dissected and trypsinized as indicated above for the primary neuron cultures. Cells were suspended in DMEM supplemented with 10 % FBS (Gibco), 2 mM glutamine, 50 U/ml penicillin, and 50 μg/ml streptomycin (Gibco). Cells were plated on poly-L-lysine (PLL)-coated 75-cm 2 culture flasks at a density of 1×10 5 cells/cm 2 and cultured in 5 % CO 2 at 37°C. After 7-10 days of incubation, cultures were purified by shaking for 20 h on an orbital shaker (180 rpm) at 37°C, resulting in cultures of 95 % glial fibrillary acidic protein (GFAP)-positive cells. Purified astrocytes were digested by trypsinization, and cells were again plated at the density of 5×10 5 /cm 2 onto PLL-coated 6-well plates and incubated in 5 % CO 2 at 37°C for 2 days before used.
Oligodendrocyte Cultures
Oligodendrocyte precursor cells (OPCs) were generated from primary mixed glial cultures mentioned above as described previously [25, 26] . Briefly, after 10 days of culture in DMEM with 10 % FBS (Gibco) and supplemented with 2 mM glutamine, 50 μg/ml streptomycin, and 50 U/ml penicillin, OPCs were shaken off based on the different adhesion properties of different glial cell types. Cell cultures were shaken first at 200 rpm, 37°C for 30 min, and rinsed with fresh DMEM with 10 % FBS (Gibco) and supplemented with 2 mM glutamine, 50 μg/ml streptomycin, and 50 U/ml penicillin. After the cells were cultured for another 14-16 h, cell cultures were shaken at 280 rpm, 37°C for 18-20 h, to collect the OPCs. Precursor cells were obtained by a sequential dislodging procedure. Purified OPCs were plated onto PLL-coated 6-well plates at the density of 4×10 4 cells/cm 2 and cultured in an oligodendrocyte growth medium which contains basal chemically defined medium (BDM) (DMEM/F12 supplemented with 4 mM L-glutamine, 50 μg/ml streptomycin, 50 U/ml penicillin, 0.1% bovine serum albumin, 1 mM sodium pyruvate, 50 μg/ml apo-transferrin, 5 μg/ml insulin, 30 nM sodium selenite, 10 nM biotin, and 10 nM hydrocortisone) supplemented with 10 ng/ml PDGF-AA and 10 ng/ml bFGF to promote cell growth. OPCs were cultured in the above growth medium for 2-3 days and passaged with DMEM/F12 supplemented with 0.01 % EDTA, 0.2 mg/ml DNase, and 5 μg/ml insulin. The supernatant was collected, and the OPCs were plated onto PLL-coated 6-well plates at the density of 8× 10 4 cells/cm 2 in a differentiation medium which contains BDM with 30 ng/ml triiodothyronine (T3), 5 μg/ml N-acetyl-L-cysteine (NAC), and 10 ng/ml ciliary neurotrophin factor (CNTF) for 6 days before used.
Primary Microglia Cultures
Primary microglia cultures were also obtained from the cerebral hemispheres of newborn mouse brains (P1-2) as previously described [27, 28] . In brief, mixed glial cells were seeded onto PLL-coated culture flasks at a density of 1× When the purified neural cells reached 80 % confluence, TNF-α+IFN-γ or LPS was pulsed into a culture medium for another 24 h of incubation. Purified neurons were harvested for AR level detection with qPCR.
Immunohistochemistry
Mice were killed by injection of an overdose of 2 % sodium pentobarbital. The animals were transcardially perfused with ice-cold saline followed by 4 % formaldehyde in 0.1 M phosphate buffer, pH 7.4, for at least 15 min at room temperature (RT). After perfusion, the spinal cords were dissected out and postfixed 4-6 h at 4°C in the same solution used for perfusion. Spinal cord tissue was then immersed into 20 % sucrose solution in 0.1 M phosphate buffer, pH 7.3, at 4°C for cryoprotection. Tissues were embedded in Tissue-Tek (Sakura Finetek, Zoeterwoude, The Netherlands), cut transversely or longitudinally into 10-μm slices in a cryostat, mounted onto glass slides, and stored at −20°C for further processing.
The sections were blocked with 1 % bovine serum albumin containing 0.3 % Triton X-100 for 1 h. Sections were then incubated with primary antibodies (see Table 1 ) overnight at 4°C. Then, sections were incubated with appropriate secondary antibody for 2 h at room temperature. Images were acquired by using an FV 1000 confocal system (Olympus, Japan).
To detect the accumulation of HNE after given ARI, we treated cultured BV2 and N9 microglia with fidarestat at 0, 20, 30, and 40 μM for 24 h. After washing for three times with PBS, the cells were fixed with 4 % formaldehyde for 10 min at RT. Cells were incubated with rabbit anti-HNE pAb (Abcam) overnight at 4°C. After washing with PBS for three times, the FITC-labeled anti-rabbit IgG was incubated for 2 h. The density of fluorescence was judged under BX53 microscopy (Olympus, Japan) with the same exposure time or with a fluorescent density scan (exCitation wavelength 493 nm and emission wavelength 518 nm) by Infinite M200 PRO (Tecan, Switzerland). All antibodies and their dilutions used in IHC in this study are listed in Table 1 .
Quantitative Real-Time PCR
The method of qRT-PCR was carried out as our previous description with slight modifications [26] . Briefly, mice were sacrificed 1, 3, 7, 14, and 21 days after SCI with an overdose of 2 % pentobarbital sodium intraperitoneal injection. A 1-cm spinal cord segment containing the injured site in the middle was removed quickly for RNA isolation. Control mice were sacrificed after the operation as well.
Total RNA was extracted using TRIzol Reagent (Invitrogen) according to the manufacturer's instructions. The concentration of RNA was measured by UV absorbance at 260 and 280 nm (260/280), while the quality was checked by gel electrophoresis. An equal amount of RNA from each group was used for Poly(A) tailing, and quantitative reverse transcription consisted of 4 μl 5× reaction mix, 2 μl 10× SuperScript Enzyme Mix, and 200 ng total RNA in a final volume of 20 μl. Then, real-time PCR was performed using the NCode TM EXPRESS SYBR GreenER TM microRNA qRT-PCR Kit (Invitrogen) containing 1 μl of the RT product, 10 μl EXPRESS SYBR Green qRT-PCR SuperMix, 0.4 μl microRNA-specific forward primer (10 μM), and 0.4 μl universal qPCR primer (10 μM) in a final volume of 20 μl. PCR cycling began with template denaturation and hot start Taq activation at 95°C for 2 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min performed in a CFX96 Real-Time PCR System (Bio-Rad). Beta-actin was used as the internal standard reference, and normalized expressions of targeted genes were calculated using the comparative CT method and fold changes were derived from the equation 2 −ΔΔCt for each gene. All primers used in this study are listed in Table 2 .
Western Blotting
Tissue samples about 1 cm of spinal cord with the injured site in the middle were lysed by homogenizing per 100 mg tissues in 1 ml radioimmunoprecipitation assay (RIPA) (50 mM Tris-HCl, pH 8.0; 150 mM NaCl; 1 % NP-40; 0.5 % sodium deoxycholate; 0.1 % SDS) buffer or the cells in 6-well plates were lysed in 300 μl RIPA buffer containing 1 mM PMSF. Lysates were centrifuged at 12,000 rpm for 10 min, and the supernatant was collected and added with the same volume of the sample buffer. The protein amount was determined using BSA Protein Assay Kit (Pierce). Samples with equal amounts of protein were then separated by 10 % SDS-PAGE and electrotransferred onto Table 1 at 4°C overnight. Membranes were then washed three times for 10 min with TBST and probed with the relative secondary antibodies conjugated with horseradish peroxidase (Abcam) at RT for 2 h. Membranes were finally washed three times for 10 min with TBST to remove unbound secondary antibodies and visualized using enhanced chemiluminescence (Thermo Scientific). The density of specific bands was measured using ImageJ densitometry software and normalized against a loading control (β-actin).
Statistical Analysis
All statistical analyses were conducted using GraphPad Prism 5.0 (GraphPad Software). All data are expressed as group mean±SEM unless otherwise noted. Comparison of the two groups was performed using independent t tests. Results were considered statistically significant at p<0.05.
Results
Time Course Changes in mRNA and Protein Levels of AR After SCI
We analyzed time-dependent changes in the expression profiles of AR transcript and protein between 4 h and 14 days postinjury (hpi or dpi) using qPCR and Western blotting (WB) in C57BL/6 mice. Starting at 4 hpi, the AR mRNA level began to increase, with a significant increase 1 dpi, and was maintained until 14 dpi according to qPCR results (Fig. 1a) . This result was subsequently confirmed by WB (Fig. 1b, c) .
The AR protein was also upregulated in a time-dependent manner after injury (Fig. 1b) . The densitometric ratio of AR/ β-actin showed that the AR protein clearly increased from 1 to 14 dpi (Fig. 1c) . These results suggest that AR expression was temporally upregulated after SCI in normal mice. We next investigated the types of neural cells showing upregulated expression of AR following SCI in mice. Based on the above results showing that both mRNA and protein levels of AR reached a peak 3 dpi in the injured spinal cord, we used the immunofluorescence double-labeling method to immunostain AR bound to other neural cell markers, such as NeuN (for neuron), GFAP (for astrocyte), Iba-1 (for microglia/ macrophages), and MBP (for oligodendrocyte), respectively. Microglia/macrophages that were Iba-1 positive also highly expressed AR adjacent to the lesion site (Fig. 1d) [6, 29] . The distal area from the lesion site of the spinal cord, however, expressed a low level of AR and Iba-1 (Fig. 1d) . Neurons adjacent to the lesion site presented both AR-and NeuN- positive signals (Fig. 1e) . We also evaluated AR expression in astrocytes and oligodendrocytes, but no double-labeled astrocytes or oligodendrocytes were observed in injured spinal cord (data not shown). These results suggest that an injured, and not a healthy spinal cord, induces AR expression in microglia, macrophages, and neurons, but not in astrocytes or oligodendrocytes. M1-polarized microglia/macrophages, which mainly secrete pro-inflammatory cytokines, such as INF-γ and TNF-α, are dominant at early stages in SCI [6, 29] . We suspected that the pro-inflammatory cytokine environment was likely to cause neural cells to upregulate AR. We isolated primary neural cells, including astrocytes, oligodendrocytes, neurons, and microglia, and cultured these cells with cytokine IFN-γ+TNF-α stimulation for 24 h in vitro, respectively. Next, we extracted RNA from the cells and measured AR expression using qPCR. Primary neurons and microglia (Fig. 1h, i ), but not astrocytes or oligodendrocytes (Fig. 1f, g ), expressed high levels of AR transcripts under pro-inflammatory cytokine stimulation (Fig. 1h, i) . In addition, under LPS stimulation, microglia expressed much higher levels of AR mRNA compared to those under pro-inflammatory cytokine stimulation (Fig. 1i) . A previous study showed that both IFN-γ and LPS can induce macrophage polarization to the M1 phenotype via IFN-γR and TLR4, respectively [1, 8, 30] . Thus, our results suggest that AR may play a role in the polarization of microglia/macrophages after SCI.
AR Deficiency Promoted Locomotor Recovery After SCI AR-deficient mice showed no apparent development, reproductive, or nervous system abnormalities except for a partially defective urine-concentrating ability [18] . However, whether AR plays a role in recovery after SCI remained unclear. We evaluated locomotor recovery based on the BMS locomotor rating scale after SCI with a severe crush model in AR −/− mice [19, 31] . AR-deficient mice exhibited significant higher BMS scores beginning at 3 dpi (Fig. 2a) . After 21 dpi, hind limb locomotion appeared to reach a plateau in both AR +/+ and AR −/− mice. At the end of the 28-dpi assessment period, AR +/+ mice showed a mean score of approximately 4 (n= 10), while the AR −/− mice had a score of 6.5 (n=8) on the BMS (Fig. 2a) . To evaluate the lesion sizes after SCI, we performed LFB staining in spinal cord sections of AR +/+ and AR −/− mice, respectively. First, we compared the lesion areas, which were evidenced by reduced LFB staining, between AR +/+ and AR −/− mice at 3, 7, and 14 dpi (Fig. 2b) . At all three time points, AR −/− mice showed much smaller lesion areas compared to AR +/+ mice after SCI (Fig. 2c) . Thus, these 
M1/M2 Ratio Decreased Significantly During Early Stages of SCI
Microglia/macrophages are critical inflammatory cells which significantly contribute to the pathological environment in SCI. They can be detrimental or beneficial to functional recovery after SCI based on their polarized subsets, M1 or M2 [1, 29, 32] . In fact, there are both M1 and M2 microglia/ macrophages present at the injured spinal cord despite whether it is an early stage or late stage in SCI. The M1/M2 ratio determines the outcome of microglia/macrophages, which is detrimental or beneficial for recovery after SCI [6, 29] . We stained injured spinal cord sections with antibodies of the M1-specific marker iNOS and M2-specific marker Arg1 combined with microglia-and macrophage-specific marker F4/ 80 or Iba-1 in AR +/+ and AR −/− mice, respectively. In AR (Fig. 2e) . These results show that more Arg1 + , but not iNOS + , microglia/macrophages were present at the injured site in AR −/− mice after SCI.
In AR +/+ mice, the iNOS mRNA increased rapidly and reached its highest level at 1 and 3 dpi. At 14 dpi, iNOS mRNA had nearly returned to normal levels in AR +/+ mice (Fig. 3a) . In AR −/− mice, however, iNOS mRNA showed no significant change at all time points compared to the sham group after SCI (Fig. 3a) . Comparison of iNOS mRNA level at 4 hpi and 1, 3, and 7 dpi in AR +/+ with AR −/− mice showed that iNOS mRNA was clearly higher in AR +/+ mice than in AR −/− mice (Fig. 3a) . Another M1 cell marker, CD86, was also detected after SCI by qPCR. The CD86 mRNA level differed from the iNOS transcription profile at 14 dpi in AR +/+ mice, which displayed clear upregulation compared to AR −/− mice (Fig. 3b) . In AR +/+ mice, Arg1 mRNA level increased rapidly over a short period of time postinjury and reached its highest expression at 3 dpi (Fig. 3c) . Arg1 mRNA level decreased suddenly at 7 dpi and recovered to its normal expression level at 14 dpi in AR +/+ mice (Fig. 3c) . The Arg1 expression pattern in AR −/− mice was similar to that in AR +/+ after SCI, in which Arg1 mRNA was upregulated rapidly after SCI, reaching its highest expression level at 1 dpi and followed by a decrease in expression; however, the pattern was quite different for Arg1 mRNA expression between the two types of mice (Fig. 3c) . In AR −/− mice, the Arg1 mRNA level was also decreasing, but it decreased slowly compared to that in AR +/+ mice at the same time point after SCI (Fig. 3c) . The mRNA of CD206, another M2 cell marker, also increased significantly at 1, 3, 7, and 14 dpi in AR −/− mice compared to that in AR +/+ mice after SCI (Fig. 3d) . The iNOS protein level was downregulated rapidly after SCI in AR −/− mice, while it was upregulated postinjury in AR +/+ mice (Fig. 3e, f) . In contrast, Arg1 was rapidly upregulated and then decreased at 14 dpi both in AR +/+ and AR −/− mice (Fig. 3e, g ). However, AR −/− mice expressed more Arg1 than AR +/+ mice at the same checkpoint postinjury (Fig. 3g) . Interestingly, we found that both iNOS and Arg1 levels were higher in AR −/− mice than in AR +/+ mice in the sham groups. It is unclear whether these results suggest that AR-deficient microglia indicate higher basic activity. Densitometric analysis showed that iNOS/β-actin was much lower in AR −/− mice than in AR +/+ mice at the same checkpoint postinjury (Fig. 3f ) while Arg1/β-actin and the ratio of Arg1/iNOS protein expression were much higher in AR −/− mice than in AR +/+ mice at the same checkpoint postinjury (Fig. 3g, h ). The characteristic markers of M2 macrophages, such as Arg1 and CD206, were upregulated rather than M1 cell markers, such as iNOS and CD86, after SCI in AR −/− mice. This suggests that macrophages and microglia may be polarized to M2 cells at the lesion site after SCI in AR −/− mice.
AR Deficiency Caused NF-κB Downregulation and CREB Upregulation After SCI in Mice
Several key transcription factors that translate signals in the microenvironment into a polarized macrophage phenotype are produced according to several reports [8, 30] . Toll-like receptor (TLR) engagement can activate NF-κB and produce inflammation mediators associated with M1 macrophages [8, 30] . In addition, the CREB-C/enhancer binding protein (EBP) axis plays an important role in macrophage polarization and induces M2 macrophage-specific gene expression [33] . ARmediated LPS-induced inflammatory signals in macrophages promote NF-κB-dependent expression of inflammatory cytokines and chemokines [16, 17, 34, 35] . AR also regulates LPS-mediated inflammation through the cAMP/PKA/CREB pathway [36] . Thus, we focused on the expression profiles of NF-κB and CREB after SCI in AR +/+ and AR −/− mice. The mRNA of the p65 subunit of NF-κB increased gradually postinjury, with AR +/+ mice showing higher mRNA levels of p65 at 1, 3, and 7 dpi compared with AR −/− mice at the same time point after SCI (Fig. 4a) . Additionally, mRNA levels of CREB were higher at 4 hpi and 1, 3, and 7 dpi in AR −/− mice (Fig. 4b) . At 14 dpi, however, the mRNA level of CREB was lower in AR −/− mice compared to that in AR +/+ mice (Fig. 4b) . In AR −/− mice, however, the profile of p65 continued to decrease after SCI (Fig. 4d) . In AR +/+ mice, the protein level of p65 gradually increased at 1, 3, 7, and 14 dpi (Fig. 4c) . Densitometric analysis indicated that NF-κB/β-actin was much higher in AR +/+ mice than in AR −/− mice at the same checkpoint postinjury (Fig. 4e) . The other transcription factor studied, CREB, also showed a different expression pattern after SCI in AR +/+ mice and AR −/− mice. In AR +/+ mice, the peak of CREB expression occurred at 14 dpi, while CREB level was highest at 3 dpi and decreased at 14 dpi in AR −/− mice (Fig. 4d) . Densitometric analysis of CREB/β-actin was much higher in AR −/− mice than in AR +/+ mice at 1, 3, and 7 dpi (Fig. 4f) . Amounts of pCREB were always higher at the same time point after SCI in AR −/− mice compared with that in AR +/+ mice (Fig. 4g) . Consistent with the higher baseline level of iNOS and Arg1 (Fig. 3e) , the levels of NF-κB, CREB, and pCREB were also higher at baseline in AR −/− mice (Fig. 4c, d ). These results showed that there were lower levels of the p65 subunit of NF-κB and higher CREB and pCREB during early stages after SCI in AR −/− mice compared to those in AR +/+ mice.
HNE and CREB Were Upregulated in Microglia Following AR Inhibition
HNE is one of the products of lipid peroxidation. It undergoes glutathione S-transferase (GST)-catalyzed conjugation to form glutathione-4-hydroxynonenal (GS-HNE), which is further reduced to GS-DHN (1,4-dihydroxynonene) by AR [15] . To confirm whether HNE increases after ARI fidarestat treatment, we measured the concentration of HNE in the BV2 microglia cell line based on fluorescence using in vitro immunohistochemistry. Compared with untreated ARI cells, HNE significantly increased in cells following ARI treatment (Fig. 5a ). The concentration of ARI from 20 to 40 μM did not obviously increase the HNE level in a dose-dependent manner (Fig. 5a ). We next detected changes in HNE levels of under 20 μM fidarestat over time using fluorescent density scanning with an Infinite M200 PRO (Switzerland). HNE level was significantly increased at 12 h after fidarestat treatment (Fig. 5b) . From 12 to 48 h after fidarestat stimulation, HNE levels were stable at a high level (Fig. 5b) . We also confirmed this phenomena using the microglial cell line N9 (data not shown). These results suggest that AR inhibition can cause HNE accumulation in microglia. Our results described above also showed that AR plays a role in the polarization process of microglia/macrophages after SCI. To further detect the mechanism of AR in the regulation of microglia polarization, we used the murine microglial cell line N9 in vitro. N9 cells were treated with dimethylsulfoxide as controls (Fig. 5c, d) . Following LPS stimulation, N9 cells were polarized to the M1 phenotype characterized by high iNOS and low Arg1 levels with p-NF-κB upregulation (Fig. 5c) . In contrast, N9 cells following IL-4 stimulation were polarized to the M2 phenotype characterized by low iNOS and high Arg1 levels similarly to macrophage polarization (Fig. 5d) [8, 30] . N9 cells were treated with HNE, a substrate of AR, resulting in upregulation of Arg1 and p-CREB and downregulation of iNOS (Fig. 5c) . The ARI fidarestat, which has been examined in phase III clinical trials for diabetic neuropathy, may also effectively upregulate Arg1 and downregulate iNOS in N9 cells, similarly to HNE (Fig. 5c) [16, [37] [38] [39] . When N9 cells were stimulated with LPS+ARI, iNOS and p-NF-κB levels were significantly downregulated, while Arg1 was upregulated (Fig. 5c ). N9 cells were pulsed with a combination of LPS + HNE, and Arg1 and p-CREB were clearly upregulated, while iNOS was downregulated (Fig. 5c) . Thus, these results suggest that HNE and ARI could induce microglia to upregulate Arg1 and downregulate iNOS, which may occur via the p-CREB pathway.
N9 cells that had been treated with a combination of LPS+ARI, LPS+HNE, and LPS+HNE+ARI all showed an increase in Arg1 expression. iNOS levels slightly increased following stimulation with these compounds compared to HNE or ARI stimulation alone, but decreased significantly compared with LPS stimulation (Fig. 5c) . Additionally, the level of p-CREB was clearly increased. However, the level of p-NF-κB was clearly decreased following stimulation with a combination of these compounds (Fig. 5c) . These results further indicate that HNE and ARI can induce Arg1 expression through the CREB pathway.
To confirm whether HNE-and ARI-induced Arg1 expression occurred via the p-CREB pathway, we used the p-CREBspecific inhibitor KG501, which can block phosphorylation of CREB, to treat N9 cells in vitro. In N9 cells treated with mice. e NF-κB normalized by β-actin. f CREB normalized by β-actin. g pCREB normalized by β-actin. *p<0.05, **p<0.01, ***p<0.001 KG501, the expression of Arg1 and p-CREB was similar to that in cells treated with dimethylsulfoxide (Fig. 5d) . The upregulation of Arg1 induced by HNE and ARI was stopped in the presence of KG501. The p-CREB expression level was also decreased in the presence of KG501 compared with treatment with HNE or ARI alone (Fig. 5d) . IL-4, which is the prototypical cytokine that polarizes macrophages into the M2 phenotype, significantly induced Arg1 upregulation and slight iNOS downregulation in N9 cells (Fig. 5d) . Combining IL-4 with KG501 to stimulate N9 cells, however, a slight decrease of Arg1 was observed compared with IL-4 stimulation alone (Fig. 5d) . These results suggest that the HNE-and ARI-induced Arg1 expression in microglia occurred through a p-CREB transcriptional factor, but IL-4 did not stimulate expression through this mechanism. 
Discussion
Inflammation appears to be the most important pathological process during secondary injury after SCI. Residential microglia and hematogenous macrophages, which are the main inflammatory subpopulations, from surrounding tissues arrive at the injury site within hours after the primary injury [12, 40] . The inflammatory response after SCI is thought as a "doubleedged sword," with both neuroprotective and neurotoxic properties based on the polarized states of microglia/macrophages [6, 29, 32] . In the first few days after injury, iNOS and proinflammatory cytokines such as TNFα, IL-1β, and IL-6 are upregulated by microglia/macrophages in SCI-induced aseptic conditions [41, 42] . These pro-inflammatory cytokines and other mediators including HMBG1, which are released from dead cells, activating microglia/macrophages through TLRs, result in NF-κB-mediated production of pro-inflammatory cytokines and iNOS activation, the hallmarks of M1 macrophage and microglia activation during early stages of SCI [1, 6, 32] . The reports of M2 polarization in SCI are controversial. In the contused spinal cord of mouse, most microglia/ macrophages are M1 cells, with only a transient and small number showing M2 polarization. The expression of one of the classic M2 markers, Arg1, was transient and returned to normal levels by 14 days postinjury [6] . A recent study reported accumulation of two distinct subsets of macrophages with different kinetics. The Ly6c hi Cx3cr1 lo macrophages, which express characteristic M1 markers (IL-1β and TNF-α), are present at 1 dpi and peaked at 3 dpi at the injury site after SCI. Subsequently, Ly6c lo
Cx3cr1
hi macrophages, which express characteristic M2 surface markers (dectin-1, IL-4Rα, and CD206), infiltrated beginning at 3 dpi and peaked at 7 dpi at the injury site after spinal cord contused injury [32] . Our results also showed that both mRNA and protein levels of Arg1 and iNOS are upregulated in early stages after SCI in AR +/+ mice. However, mRNA and protein levels of Arg1 and iNOS were expressed with diverging patterns; Arg1 was upregulated, while iNOS was downregulated during early stages after SCI in AR-deficient mice. The M2-type microglia/macrophages were dominant at the injured spinal cord in AR −/− mice, whereas M1 cells dominated in AR +/+ mice at early stages after SCI. This suggests that AR plays a critical role in the polarization of microglia/macrophages after SCI in mice. AR was described in 1956 by Hers to have glucosereducing activity [43] . Recent several reports have shown that AR mediates LPS-induced inflammatory signals in macrophages [14, 15, 17, 35, 36, 39] . Inhibition of AR by several ARIs such as sorbinil, tolrestat, and zopolrestat suppresses LPS-induced production of inflammatory cytokines such as TNF-α, IL-6, IL-1β, IFN-γ, and chemokine MCP-1 in murine peritoneal macrophages. Inhibition of AR also prevents the production of NO and prostaglandin E2 (PGE2) and expression of iNOS and Cox-2 mediated by inhibiting phosphorylation of IκB-α, IKKα/β, and protein kinase C (PKC) [35] . These studies demonstrate that AR inhibition or ablation can prevent macrophage polarization into the M1 phenotype. In this study, we confirmed that AR deficiency decreases the number of microglia/macrophages with the M1 phenotype after SCI.
AR mediates inflammatory signals in macrophages mainly through regulating oxidative stress responses [14] . Macrophages are polarized to the M1 response by either producing pro-inflammatory cytokines or increasing the generation of ROS [44] . ROS-induced lipid peroxidation-derived compounds such as HNE and their glutathione conjugates (e.g., GS-HNE) are produced in large amounts in cells [14, 16] . AR efficiently catalyzes the reduction of HNE and GS-HNE to 1,4-dihydroxynonene (DHN) and GS-DHN, respectively, with much lower Km values in the micromolar range (10-30 μM) than the Km value for glucose (50-100 mM) [15, 16] . Pharmacological inhibition or genetic ablation of AR prevents PLC, PKC, and NF-κB activation caused by HNE and GS-HNE, but not by GS-DHN [15] . Thus, inhibiting AR prevent macrophages from polarizing to M1, which may be due to the reduction in HNE/GS-HNE to DHN/GS-DHN; this can activate the redox-sensitive transcriptional factors NF-κB and AP-1 to upregulate expression of genes characteristic of M1 macrophages (Fig. 6a) [15, 16] . AR inhibition can prevent LPS-induced downregulation of cAMP response element modulator (CREM), phosphorylation of CREB, and DNA binding of CREB in macrophages [36] . Another report showed that HNE could induce ATF-2 and CREB-1 phosphorylation to regulate the secretion of some cytokines [45] . These data show that HNE and GS-HNE can trigger multiple signaling cascades to modulate inflammatory responses [15, 45] . In this study, we found that AR deficiency not only decreased M1 polarization but also increased the M2 phenotype of microglia/macrophages after SCI. In vitro experiments showed that inhibiting AR with fidarestat upregulated HNE in microglia. HNE accumulation induced Arg1 upregulation by activating CREB, which could be specifically inhibited by KG501 in microglia. However, the upregulation of Arg1 induced by IL-4 and transcribed by STAT6 was not inhibited by KG501 [8] . Thus, we hypothesize that AR controls the switch resulting in accumulation of HNE in cells. If AR is sufficient, HNE/GS-HNE will be reduced to DHN/GS-DHN, which activates NF-κB and AP-1 to polarize microglia to M1 type [17] . However, if AR is inhibited or ablated, HNE/GS-HNE will accumulate in the cytoplasm and activate CREB to polarize microglia to the M2 type (Fig. 6a, b) [36, 45] .
CREB is a pivotal transcriptional factor in macrophage polarization that promotes activation of M2-associated genes with repressing of M1 activation [33, 46, 47] . CREB induces C/EBPβ expression, which specifically regulates M2-associated genes [33] . Both STAT6 and C/EBPβ have recently been shown to be essential for Arg1 expression in macrophages, but in a stimulus-specific manner due to the selective use of a distinct cis-acting element in the Arg1 promoter [47] . C/EBPβ is responsible for Arg1 expression in response to TLR ligands, whereas STAT6 regulates Arg1 expression in response to IL-4 and/or IL-13 stimulation [8, 47] . CREB also shows anti-inflammatory cytokine expression in macrophage in response to LPS, which is mediated by the p38 mitogen-activated protein kinase (MAPK) and mitogenand stress-activated kinase 1 (MSK1) and MSK2 [46] . As it was shown previously, the M1-polarized microenvironment with high pro-inflammatory cytokines (e.g., IL-1β and IL-6) and TLR ligands (e.g., HMGB1) is dominant, which is preferred for polarizing microglia/macrophages into the M1 type during early stages of SCI [1, 41, 42] . In this study, we found that AR deficiency could switch microglia/macrophages polarized to the M2 type rather than the M1 type even at early stages of an M1-polarized microenvironment, such as in injured spinal cord. Thus, it is reasonable that AR deficiency causes accumulation of HNE in microglia, which stimulates CREB to regulate the expression of characteristic M2 genes with the repression of M1-associated genes (Fig. 6b) .
AR can be detected in a number of human and animal tissues including various regions of the eyes, testis, liver, placenta, ovary, kidney, erythrocyte, cardiac and skeletal muscle, and the brain [48] . AR is located in the cytoplasm of most cells but is not uniformly distributed in all cell types of an organ. For example, in the kidney, AR is present in the loop of Henle, collecting tubules, and outer and inner medulla, but not in the cortex [49] . In this study, we also found that although the levels of both mRNA and protein of AR are gradually upregulated after injury in a time-dependent manner, AR is only distributed in microglia, macrophages, and neurons, but not in astrocytes or oligodendrocytes near the injured site after SCI. Quantitative proteomic analysis of purified in vivo retinal ganglion cells (RGCs) showed that AR is one of the most significantly elevated proteins in experimental glaucoma [50] . The roles of AR in the nervous system primarily result from diabetic complications, such as retinopathy and neuropathy [50] . Previous studies demonstrated that hyperglycemiainduced oxidative stress leads to activation of MAPK, which may contribute to neuronal pathogenesis. Fidarestat, an AR inhibitor, was shown to prevent activation of MAPK and nerve conduction velocity deficits in diabetes [51, 52] . Studies using AR-knockout mice [18] also demonstrated that AR deficiency could prevent diabetes-induced oxidative stress in retinal neurons [53] . Moreover, both AR deficiency and AR inhibition reduced oxidative stress in the peripheral nerves and markedly protected mice from diabetes-induced functional deficits [51] . However, there have been few reports regarding the role of AR in neuronal cells in the CNS. In this study, we found that AR was upregulated in neurons near the lesion site of the spinal cord after injury. The significance of AR upregulation in neurons after SCI remains unclear. However, we also found that AR deficiency promotes axonal regeneration of primary cultured cortical neurons in vitro (data not shown). We suggest that AR plays multiple roles in neural and nonneural cells.
AR inhibition is emerging as a promising therapeutic approach in understanding the cellular and molecular mechanisms of AR [54] . Although ARI-targeted therapies are currently being evaluated in phase I/II and III studies for diabetes and endotoxin-related inflammatory diseases, yet they have not achieved worldwide clinical use in disease management because of limited efficacy and/or unfavorable adverse effects [54] . To explore the AR-mediated signaling pathway in different tissues and cells may be critical to increase efficacy and decrease side effects of ARIs in the future. In this study, we found that AR has a critical role in switching microglia/ macrophage polarization after SCI. We suggest that AR Fig. 6 Schematic presentation of the mechanism of AR in the regulation of M1/M2 polarization. a AR typically reduces HNE/GS-HNE to DHN/ GS-DHN which activates NF-κB and AP-1 to induce the M1-associated gene expression. b In AR inhibition or AR deficiency, the reduction of AR is decreased and causes the accumulation of HNE/GS-HNE, which activates CREB to induce the M2-associated gene expression inhibition may be a promising therapeutic method for treating SCI in the future.
